Evidence map›Paper›PMID 32687611›Full record

ArticleImmunology2020

Quantifying immunoregulation by autoantigen-specific T-regulatory type 1 cells in mice with simultaneous hepatic and extra-hepatic autoimmune disorders.

Hassan Jamaleddine, Pere Santamaria, Anmar Khadra

Open access · greenAbstract read
In one paragraph

Article in Immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Hassan JamaleddineDepartment of Physiology, McGill University, Montreal, QC, Canada.ORCID 0000-0002-4026-492X
Pere SantamariaDepartment of Microbiology, Immunology & Infectious Diseases, University of Calgary, Calgary, AL, Canada.
Anmar KhadraDepartment of Physiology, McGill University, Montreal, QC, Canada.ORCID 0000-0002-8228-9914
McGill University · CAUniversity of Calgary · CA

Funding

Crohn's and Colitis Foundation of CanadaDiabetes CanadaFonds Nature et technologies - Gouvernement du Quebec Team grantGeneralitat de CatalunyaInstitute of Infection and ImmunityMinisterio de Economia y Competitividad of Spain RTI2018-093964-B-I00Multiple Sclerosis Society of CanadaNatural Sciences and Engineering Council of Canada Discovery grant
6 · The paper itself

Abstract

Nanoparticles (NPs) displaying autoimmune disease-relevant peptide-major histocompatibility complex class II molecules (pMHCII-NPs) trigger cognate T-regulatory type 1 (Tr1)-cell formation and expansion, capable of reversing organ-specific autoimmune responses. These pMHCII-NPs that display epitopes from mitochondrial protein can blunt the progression of both autoimmune hepatitis (AIH) and experimental autoimmune encephalomyelitis (EAE) in mice carrying either disease. However, with co-morbid mice having both diseases, these pMHCII-NPs selectively treat AIH. In contrast, pMHCII-NPs displaying central nervous system (CNS)-specific epitopes can efficiently treat CNS autoimmunity, both in the absence and presence of AIH, without having any effects on the progression of the latter. Here, we develop a compartmentalized population model of T-cells in co-morbid mice to identify the mechanisms by which Tr1 cells mediate organ-specific immunoregulation. We perform time-series simulations and bifurcation analyses to study how varying physiological parameters, including local cognate antigenic load and rates of Tr1-cell recruitment and retention, affect T-cell allocation and Tr1-mediated immunoregulation. Various regimes of behaviour, including 'competitive autoimmunity' where pMHCII-NP-treatment fails against both diseases, are identified and compared with experimental observations. Our results reveal that a transient delay in Tr1-cell recruitment to the CNS, resulting from inflammation-dependent Tr1-cell allocation, accounts for the liver-centric effects of AIH-specific pMHCII-NPs in co-morbid mice as compared with mice exclusively having EAE. They also suggest that cognate autoantigen expression and local Tr1-cell retention are key determinants of effective regulatory-cell function. These results thus provide new insights into the rules that govern Tr1-cell recruitment and their autoregulatory function.

Indexed as

Models, ImmunologicalModels, TheoreticalAnimalsAntigen PresentationAutoantigensCell CompartmentationEncephalomyelitis, Autoimmune, ExperimentalHepatitis, AutoimmuneHumansImmunomodulationLymphocyte ActivationMiceMultiple SclerosisNanomedicineT-Lymphocytes, RegulatoryAutoantigenscompartmental cell population modelnanomedicinesimultaneous autoimmune disorderssteady-state and transient dynamicsTr1-cell recruitment and retention

Identifiers

PMID32687611
PMCPMC7576881
OpenAlexW3045482742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.